Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2025 ∙ Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
Adults Older adults Pneumococcal disease Economic aspects
Rating:
Not applicable
2025 ∙ Deese, J. Schaible, K. Massierer, D. Tingir, N. Fell, D. B. Atwell, J. E.
Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation Tetanus, Pertussis, Influenza and COVID-19
Pregnant women Tetanus Pertussis Influenza COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Milne, B. M. Mallett, E. M. Brogly, S. B.
The Effect of COVID-19 Vaccination on Menstrual Cycles of Adolescents and Young Adults: A Systematic Review and Meta-analysis
Adolescents Adults COVID-19 Safety
Rating:
Low
2025 ∙ Lei, Z. J. Bai, M. X. Li, M. J. Jin, P. Ding, Y. B.
The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis
Pregnant women COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Yan, X. Liu, Y. Chen, F. Chang, Z. Zhang, Z. Pons-Salort, M. Grassly, N. C.
The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis
Western Pacific China Newborn Children Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Shahrebabak, A. G. Rezaei, M. Shahpar, A. Nezhad, N. Z. Sarasyabi, M. S. Nakhaie, M. Shahrebabak, M. G. Bahri, R. A.
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Zarekar, M. Al-Shehabi, H. Dorner, R. Weishaar, H. Lennemann, T. El Bcheraoui, C. Bernasconi, A.
The impact of information and communication technology on immunisation and immunisation programmes in low-income and middle-income countries: a systematic review and meta-analysis
Children Low and Middle Income Countries Coverage Logistics
Rating:
Not applicable
2025 ∙ Wu, W. Liu, J. Guo, S. Zhao, H. Yang, X.
The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome A meta-analysis
All age groups Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Shuai, T. Dong, M. Wu, P. Zhang, L. Feng, Z. Li, W. Liu, J.
The safety and efficacy of non-typeable Haemophilus influenzae and Moraxella catarrhalis vaccine in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
All age groups Haemophilus influenzae type B Moraxella catarrhalis Efficacy/effectiveness Safety
Rating:
Moderate
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.
Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Rating:
Critically low
Loading...